Weekly Recap: 15 Health Press Releases You Need to See

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including the first use of Johnson & Johnson's robotic surgical system and a staggering global statistic on pediatric antimicrobial resistance.

NEW YORK, April 18, 2025 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed.

The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download.

    1. Johnson & Johnson MedTech Announces Completion of First Cases with
       OTTAVA(TM) Robotic Surgical SystemOTTAVA is designed as a multi-specialty
       soft-tissue surgery robot, supporting a broad range of procedures across
       patient anatomy and surgical specialties, including the most complex
       surgeries that require a multi-quadrant approach.

    2. Novo Nordisk warns consumers about counterfeit Ozempic(®) (semaglutide)
       injection 1 mg in the USNovo Nordisk has become aware of several hundred
       units of Ozempic(®) (semaglutide) injection 1 mg distributed outside the
       Novo Nordisk authorized supply chain in the US. The US Food and Drug
       Administration (FDA) has also updated its website with information about
       these counterfeit versions of Ozempic.

    3. IMDELLTRA(®) Demonstrated Superior Overall Survival in Small Cell Lung
       CancerIMDELLTRA demonstrated statistically significant and clinically
       meaningful improvement in overall survival (OS) compared to local
       standard-of-care (SOC) chemotherapy. Jay Bradner, M.D., executive vice
       president, Research and Development, at Amgen, commented on the
       "overwhelming clinical benefit" stating the results "affirm IMDELLTRA as
       standard of care."

    4. The Elizabeth Taylor AIDS Foundation Issues Emergency Grant Cycle to
       Address Forthcoming Gap FundingProviding financial resources to
       organizations in need, the initiative will be aimed at ensuring that
       critical, wrap-around health services for HIV treatment & prevention and
       programs focused on Transgender communities can continue to operate into
       the near future.

    5. Over 3 million children died from AMR-related infections in 2022, major
       study showsThe study data found that in 2022 alone, more than 752,000
       children in Southeast Asia and 659,000 children in Africa died of
       antimicrobial resistance (AMR)-related infections. Globally, of the more
       than 3 million children's deaths, 2 million were associated with the use
       of Watch and Reserve antibiotics.

    6. SHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower
       Reactogenicity Symptoms Compared to mRNAPreliminary data showed Novavax's
       non-mRNA JN.1 COVID-19 vaccine induced lower frequency and severity of
       short-term side effects and impact on daily life compared with
       Pfizer-BioNTech mRNA vaccine.

    7. Crunch Fitness Announces Strategic Investment from Leonard Green &
       PartnersUnder the terms of the agreement, LGP will acquire a majority
       interest in Crunch Fitness from TPG Growth, the middle market and growth
       equity platform of global alternative asset management firm TPG, and
       Crunch's minority shareholders.

    8. Lilly's oral GLP-1, orforglipron, demonstrated statistically significant
       efficacy results and a safety profile consistent with injectable GLP-1
       medicines in successful Phase 3 trial"As a convenient once-daily pill,
       orforglipron may provide a new option and, if approved, could be readily
       manufactured and launched at scale for use by people around the world,"
       said David A. Ricks, Lilly chair and CEO.

    9. Hyundai Hope on Wheels Commemorates 27th Anniversary with $27 Million
       Donation to Pediatric Cancer Research"Hyundai Hope on Wheels has been a
       driving force in pediatric cancer research for nearly three decades, and
       we are proud to expand its reach beyond the U.S. to support children
       throughout North America," said Randy Parker, president and CEO, Hyundai
       Motor North America.

    10. Norgine strengthens rare disease portfolio with acquisition of
        TheraviaThe acquisition of Theravia from Mérieux Equity Partners
        represents a meaningful step forward in Norgine's strategy for
        sustainable growth, adding a complementary portfolio of rare disease
        medicines.

    11. New Docuseries People Worth Caring About Shines a Light on Ohio's
        Long-Term Care WorkersLong-term care workers play a critical role in the
        well-being of hundreds of thousands of Ohio residents, yet their stories
        often go untold. People Worth Caring About seeks to change that by
        showcasing the personal and professional journeys of these caregivers,
        illuminating the challenges they face and the deep fulfillment they find
        in their work.

    12. Illumina and Tempus partner to drive the future of precision medicine
        through genomic AI innovationThe collaboration will combine leading
        Illumina AI technologies with Tempus's comprehensive multimodal data
        platform to train genomic algorithms and ultimately accelerate clinical
        adoption of molecular testing for patients.

    13. Recently Discovered Immune Cell Type Is Key to Understanding Food
        AllergiesA new study led by researchers at NYU Langone Health has
        revealed that a special group of cells in the intestines tamp down the
        immune responses caused by exposure to food proteins. Called
        "tolerogenic dendritic cells," these cells enable food to pass through
        the body without triggering an immune reaction, unless they malfunction
        to cause allergies.

    14. Optellum Announces Agreement with Bristol Myers Squibb to Leverage AI to
        Boost Early Lung Cancer DiagnosisOptellum's Virtual Nodule Clinic (VNC)
        is the first FDA-cleared AI-powered decision support tool for
        early-stage lung cancer, reimbursed by CMS and implemented by leading
        health systems.

    15. New Research to Examine the Impact of Service Dogs On Post Traumatic
        Growth in Veterans with PTSD"Most research on PTSD has focused on the
        negative impacts of trauma exposure, but more recently, there has been
        growing interest in the potential for positive shifts after traumatic
        experiences," said Dr. Kevin Morris, the Principal Investigator of this
        research project. "We hypothesize that pairing veterans with PTSD and
        psychiatric service dogs will help promote this positive growth, which
        may include feelings of hope, agency, and a sense of purpose or meaning
        in life."

For more news like this, check out all of the latest health-related releases from PR Newswire.

Do you have a health press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most.

Helping Journalists Stay Up to Date on Industry News

These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists.

Once they're signed up, reporters, bloggers, and freelancers have access to the following free features:

    --  Customization: Users can create customized newsfeeds that will deliver
        relevant news right to their inbox. Newsfeed results can be targeted by
        keywords, industry, subject, geography, and more.
    --  Photos and Videos: Thousands of multimedia assets are available to
        download and include in a journalist or blogger's next story.
    --  Subject Matter Experts: Journalists will have access to ProfNet, a
        database of industry experts to connect with as sources or for quotes in
        their articles.
    --  Related Resources: Our journalist- and blogger-focused blog, Beyond
        Bylines, features regular media news roundups, writing tips, upcoming
        events, and more.

About PR Newswire

PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

For questions, contact the team at media.relations@cision.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/weekly-recap-15-health-press-releases-you-need-to-see-302432004.html

SOURCE PR Newswire